Does standardizing cervical ripening improve vaginal deliveries?
Official title: Impact of Standardization on Outcomes Following Cervical Ripening
Run by Indiana University · NCT07576881 · Data updated 2026-11-12
This study tests whether using standardized methods to ripen the cervix helps more pregnant people have vaginal deliveries.
Quick facts
| Phase | Phase2; Phase3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 1158 (estimated) |
| Sponsor | Indiana University Academic / other |
| Locations | 1 site (Indianapolis, Indiana) |
| Status | Recruiting |
| Started | July 29, 2026 |
| Main results expected | December 2027 |
| Study ends | April 2028 |
| Registry record updated | October 27, 2026 |
| Trial ID | NCT07576881 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 or older scheduled for medically indicated or elective induction at ≥37 weeks gestation, able to consent and read English, Spanish, or Haitian Creole.
✕Probably not a fit
Patients with cervical or fetal conditions that necessitate alternative management or those who do not undergo induction may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This Phase 2/3 trial compares three approaches to cervical ripening in labor induction: double balloon catheter alone, double balloon catheter with misoprostol, and usual care. The primary outcome is the rate of spontaneous vaginal delivery, with secondary outcomes including time to delivery, total hospital stay, operative delivery, tachysystole, fetal status interventions, and maternal and neonatal morbidity and length of stay. The study enrolls pregnant patients at ≥37 weeks undergoing indicated or elective induction at Eskenazi Hospital, with consent and language access in English, Spanish, or Haitian Creole. Results will inform whether standardizing ripening methods improves labor outcomes and whether different methods have distinct effects on maternal and neonatal safety.
Why it matters
Potential benefit: If successful, standardizing cervical ripening could increase vaginal delivery rates and improve overall labor outcomes for patients undergoing induction.
How similar studies have gone: Previous research in labor induction has explored standardized approaches, with mixed results; this trial extends to a combined, multi-arm comparison in a real-world setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who are scheduled for medically indicated or elective induction of labor with gestational age ≥37 weeks at Eskenazi hospital * Willing and able to provide informed consent * Age ≥18 years old * Able to read, speak and understand English, Spanish or Haitian Creole Exclusion Criteria: * Premature rupture of membranes * Known chorioamnionitis * Fetal malpresentation * Placenta previa * Category 3 fetal heart rate tracing -- only at the time of screening and enrollment. If a Category III tracing develops later in labor, this will prompt standard obstetric management, not removal from the study. * Prior uterine scar (cesarean delivery or other contraindication to use of prostaglandins) * Major fetal anomalies known at the time of enrollment that are expected to meaningfully impact labor management * Multiple gestation * Allergy to misoprostol or other contraindication to induction of labor or use of misoprostol or cook cervical ripening balloon * Patient does not require cervical ripening (SBS ≥ 6 or dilation ≥ 4cm) * Significant acute or chronic medical, neurologic, or illness in the patient that, in the judgment of the Principal Investigator, could compromise subject safety, limit the ability to complete the study, and/or compromise the objectives of the study
Where it's running
-
Sidney & Lois Eskenazi Hospital
Indianapolis, Indiana, United States Recruiting
Study contacts
- Study coordinator: Shelley Dowden, BS
- Email: sburn@iu.edu
- Phone: 317-880-3954
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pregnant Women Living with HIV on Bictegravir/Emtricitabine/Tenofovir Alafenamide
This study looks at how B/F/TAF is used in pregnant women with HIV and whether it helps maintain viral suppression from before conception through delivery.
-
Pelvic Floor Training and a Modified Lumbopelvic Belt for Symphysis Pubis Pain in Pregnancy
This study tests whether pelvic floor muscle training plus a modified lumbopelvic belt can reduce pain and improve function for pregnant women with symphysis pubis pain.
-
Effective Communication in VBAC Counseling
This study tests how clearly doctors and midwives explain VBAC options during prenatal visits and whether patients feel understood.
-
Innovative Multidisciplinary and Virtual Care for IBD in Pregnancy
This study tests a dedicated IBD pregnancy care model, including a new virtual approach, to see if it improves access and quality of care for pregnant people with Crohn's disease or ulcerative colitis.
-
Compare spinal-epidural versus general anesthesia for babies after cesarean delivery
This trial tests whether the type of anesthesia used for cesarean delivery affects newborn hearing in babies.
-
Pregnant women weight-management support via an app and care model
Aims to try a smartphone-based weight-management program plus professional support for pregnant women to see if it helps manage gestational weight and promote healthy behaviors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.